Tue Micheelsen

Tue Micheelsen currently serves as President of North America and Head of Global Consumer Health at Novonesis, the largest bio-solutions company resulting from the merger of Novozymes and Christian Hansen. With significant experience in leadership positions within Novozymes since 2003, including roles such as Vice President of Consumer Biosolutions and Global Sales & Marketing for Household Care, Tue has a strong background in commercial operations across various regions, including Asia Pacific and Europe. Additionally, Tue is a board member of Novo Nordisk Pharmatech A/S, a leading biotech company specializing in pharmaceutical production technologies. Educational qualifications include advanced degrees from Copenhagen Business School and executive programs at Harvard Business School and INSEAD.